Florida Society of Clinical Oncology Inc

Nonprofit profile at a glance

EIN
592305471
IRS 990 coverage
2011–2024
Forms available
Form 990 2024
Location
Riverview, FL, USA
Phone
8136770246
Rating
67
Verdict
SUPPORTED
Rating confidence
Moderate
Sector
Cancer

Official website

Reported finances

Revenue
$3,795,093
Expenses
$2,569,605
Assets
$5,865,661
Liabilities
$15,372

Source: IRS Form 990. Selected filing: tax year 2024. Amounts in USD.

Leadership & pay

46 people listed

Executive titles in this filing

  • EDGARDO SANTOS CASTILLERO MD FACP (VICE PRESIDENT)
  • MAEN HUSSEIN MD (PRESIDENT)
  • WINSTON TAN MD (PAST PRESIDENT)
  • JULIE NEWBERRY (EXECUTIVE DIRECTOR)

Highest reported compensation

  • JULIE NEWBERRY (EXECUTIVE DIRECTOR): $206,792 total reported compensation

Source: IRS Form 990. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.

Overview

Mission

The Florida society of clinical oncology is a statewide non-profit organization committed to facilitating and promoting multidisciplinary efforts to improve patient care in Florida by:- fostering access to quality cancer care to the citizens of Florida.- assisting the cancer practitioners in providing the most cost effective quality care for their patients.- acting as an advocate for Florida cancer patients and their families.- coordinating the dissemination of information and providing an opportunity for oncologists, physicians, and other health care professionals to network and exchange information.

What it reported doing in 2024

Education and professional developmentflasco provides year-round educational programming to advance oncology practice and improve patient careacross Florida. In 2024, flasco hosted over ten in-person meetings for clinicians, along with a statewidewebinar and an educational podcast to expand access to learning. Major events included the spring congressand business of oncology summit, the fall session and oncology congress, and multiple offerings within theclinical oncology series. These activities brought together physicians, nurses, pharmacists, and otherprofessionals for updates on clinical advances, practice management, and emerging therapies.specialty activities focused on advanced practice providers, nursing education, financial toxicity, and rapidintegrations in clinical practice. Flasco also provided education on legislative and policy issues that affectoncology delivery and patient access to care, helping clinicians understand and navigate changes that impacttheir ability to serve patients.flasco continued to invest in early-career development through the flasco young investigator award and fellowship travel grants that support participation in national oncology meetings. Membership in flasco isprovided at no cost to all clinicians and trainees, with additional opportunities for mentorship, committeeservice, and leadership development.communication and member engagementflasco maintains active communication channels to connect members and disseminate timely information. In2024, flasco distributed newsletters, podcasts, and digital updates highlighting clinical education, practiceresources, and member recognition. Ongoing outreach, including practice visits, regional roundtables, andnetworking events, fostered collaboration across institutions and specialties, strengthening the statewideoncology community.

Operating model

Revenue model
Membership-supported. 66% of the money available for current operations came from membership dues.
Distribution model
Direct operator. The filing allocates 95% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.

The verdict

SUPPORTED - The filed numbers largely add up and most voting board members are independent. A relatively small share of available resources goes toward mission work and some filing-based governance responses are negative or unanswered.

Rating breakdown

  • Financial Efficiency: 53
  • Transparency & Controls: 75
  • Accountability: 74
  • Sustainability: 74
  • Growth: 100

Detailed rating inputs

Financial Efficiency

  • Mission deployment rate: 51.1%; rating input score 51
  • Program expense ratio: 73.5%; rating input score 74
  • Fundraising efficiency: Limited

Transparency & Controls

  • Consistency checks: 100%; rating input score 100; 63rd percentile among comparable filings
  • Pay-setting controls: 1 of 6 controls in place; rating input score 17
    • Compensation committee: Missing
    • Independent consultant: Missing
    • Other Form 990s reviewed: Missing
    • Written employment contract: Missing
    • Compensation survey or study: Missing
    • Board or committee approval: Pass
  • Foreign activity oversight: Limited
  • Grant itemization coverage: 100%; rating input score 100; 72nd percentile among comparable filings
  • Major donor itemization: Yes; rating input score 100
  • Related-party transparency: Limited

Accountability

  • Independent voting board: 100%; rating input score 100; 63rd percentile among comparable filings
  • Governance controls: 3 of 8 controls in place; rating input score 38
    • Conflict-of-interest policy: Pass
    • Whistleblower policy: Fail
    • Document-retention policy: Fail
    • CEO compensation review process: Pass
    • Other executive compensation review process: NotApplicable
    • Form 990 shared with the board: Fail
    • Board meeting minutes documented: Pass
    • Audit committee oversight: Missing
    • Independent financial-statement audit: Fail

Sustainability

  • Operating margin: 32.3%; rating input score 85; 85th percentile among comparable filings
  • Total-asset coverage ratio: 2.28; rating input score 66; 66th percentile among comparable filings
  • Liabilities to assets ratio: 0; rating input score 91; 91st percentile among comparable filings
  • Officer compensation ratio: 8%; rating input score 37; 37th percentile among comparable filings

Growth

  • Program expense growth: 11.9% per year; rating input score 100; 70th percentile among comparable filings
  • Revenue growth: 13.3% per year; rating input score 100; 78th percentile among comparable filings
  • Asset growth: 12.7% per year; rating input score 100; 68th percentile among comparable filings

Details

  • Where the money goes: 51.1% of revenue deployed · 73.5% of spending went to programs
  • Governance: 45 of 45 board members independent · 3 of 8 filing controls reported
  • Programs: 1 filed program accomplishment · $1.9M in reported program spending
  • Leadership: top reported pay $207K · 46 people listed · 1 of 6 pay-setting controls reported
  • Consistency: 28 of 28 current checks pass
  • Schedules: 6 filed schedules · includes major donors, grants, and executive pay
  • Filing history: 14 filing years from 2011 to 2024
  • Contacts: How to reach this organization
  • Money network: 2 filed money-flow records
  • Related organizations: 1 filed related-organization link
  • Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
  • People: Everyone the filings name, and which of them the filings identify by more than a name.

Key Signals

Signals prioritize questions for review. They are not findings of misconduct.

  • Review — Financial Efficiency: Mission deployment rate scored 51/100.
  • Moderate — Accountability: Governance controls: 4 of 7 not reported.
  • Moderate — Sustainability: Officer compensation ratio scored 37/100.